Key result
Metabolic syndrome is linked to ~32% higher incident HF risk in non-diabetics with established CVD.
Why the study?
In patients with established cardiovascular disease, the relationship between metabolic syndrome and incident heart failure in the absence of diabetes mellitus was largely unknown.
Does metabolic syndrome increase the risk of incident heart failure in non-diabetic patients with established cardiovascular disease?
Cohort (n=4,653)
Does metabolic syndrome increase the risk of incident heart failure in non-diabetic patients with established cardiovascular disease?
Effect estimate: HR 1.32 (95% CI 1.04-1.68)
In non-diabetic patients with established cardiovascular disease, metabolic syndrome and insulin resistance independently increase the risk of incident heart failure.
Supports HF risk stratification by metabolic syndrome in non-diabetic CVD; leaves open whether intervention reduces incident HF.
BACKGROUND: In patients with established cardiovascular disease (CVD), the relation between metabolic syndrome (MetS) and incident heart failure (HF) in the absence of diabetes mellitus (DM) is largely unknown. This study assessed this relation in non-diabetic patients with established CVD. METHODS: Patients from the prospective UCC-SMART cohort with established CVD, but without DM or HF at baseline were included (n = 4653). MetS was defined according to the Adult Treatment Panel III criteria. Insulin resistance was quantified using the homeostasis model of insulin resistance (HOMA-IR). The outcome was a first hospitalization for HF. Relations were assessed using Cox proportional hazards models adjusted for established risk factors: age, sex, prior myocardial infarction (MI), smoking, cholesterol, and kidney function. RESULTS: During a median follow-up of 8.0 years, 290 cases of incident HF were observed (0.81/100 person years). MetS was significantly related to an increased risk of incident HF independent of established risk factors (hazard ratio [HR] 1.32; 95% confidence interval [CI] 1.04-1.68, HR per criterion 1.17; 95% CI 1.06-1.29), as was HOMA-IR (HR per standard deviation [SD] 1.15; 95% CI 1.03-1.29). Of the individual MetS components, only higher waist circumference independently increased the risk of HF (HR per SD 1.34; 95% CI 1.17-1.53). Relations were independent of the occurrence of interim DM and MI, and were not significantly different for HF with reduced vs preserved ejection fraction. CONCLUSION: In CVD patients without a current diagnosis of DM, MetS and insulin resistance increase the risk of incident HF independent of established risk factors.
No takes yet. Share an insight, caveat, or question.
Burger et al. (2023) conducted a cohort in Established cardiovascular disease (n=4,653). Metabolic syndrome was evaluated on First hospitalization for heart failure (HR 1.32, 95% CI 1.04-1.68). Metabolic syndrome was associated with an increased risk of incident heart failure in non-diabetic patients with established cardiovascular disease (HR 1.32; 95% CI 1.04-1.68).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: